Value in hypertension treatment Bradford C. BerkJohn D. Bisognano Clinical Trials Report Pages: 411 - 413
Myocardial Metabolism: A new target for the treatment of heart disease? Heinrich TaegtmeyerRebecca Salazar Clinical Trials Report Pages: 414 - 415
Insulin signaling in heart muscle: Lessons from genetically engineered mouse models E. Dale Abel OriginalPaper Pages: 416 - 423
Altered cardiac calcium handling in diabetes Darrell D. BelkeWolfgang H. Dillmann OriginalPaper Pages: 424 - 429
Arterial stiffness and wave reflection in hypertension: Pathophysiologic and therapeutic implications Gary F. Mitchell OriginalPaper Pages: 436 - 441
Angiotensin II and abdominal aortic aneurysms Alan DaughertyLisa Cassis OriginalPaper Pages: 442 - 446
Pharmacogenetic study of statin therapy in cholesterol reduction Theodore A. Kotchen Clinical Trials Report Pages: 449 - 450
Nicardipine or Labetalol as short-term treatment for severe hypertension of pregnancy George MansourJanette Mansour Clinical Trials Report Pages: 451 - 452
Hypertension management: Special considerations in chronic kidney disease patients James P. SmithJulia B. Lewis OriginalPaper Pages: 462 - 468
Pheochromocytoma: Diagnosis and management update William M. MangerGraeme Eisenhofer OriginalPaper Pages: 477 - 484
Evolution of diagnostic criteria for primary aldosteronism: Why is it more common in "drug-resistant" hypertension today? Clarence E. Grim OriginalPaper Pages: 485 - 492
